RESULTS After Model of EAhy926 cell injured by homocysteine was made, we found that cultured with 0.5, 1.0, 2.0, 4.0, 8.0 mmol/L homocysteine, cells grew less than cultured with normal culture medium, Cells cultured with homocysteine 4.0 mmol/L for 24h was made to be the model of injury. To detect the effect of aconine on EAhy926 cell injured by homocysteine, well growing EAhy926 cells were cultured in culture plate. 24h later, cells were cultured with DMEM medium containing 2% fetal calf serum for 8 hours to make cells hungry, then cultured with medium containing aconine 0, 0.05, 0.10, 0.20 mg/ml respectively for 30 minutes, then cultured with medium containing homocysteine 4.0mmol/L for 24h. It was found that, compared with control group, attached cells in aconine groups grew better, and attached cells in aconine 0.20 mg/ml plus homocysteine 4.0 mmol/L group grew best. Detected by nitrate reductase method, it was found that compared with control group, there was no obvious change of NO concentration of cell culture fluid in aconine 0.20 mg/ml group, but in homocysteine 4.0 mmol/L medol group, NO concentration of cell culture fluid decreased oberviously, and in aconine groups, NO concentration of cell culture fluid increased, and in aconine 0.20mg/ml plus homocysteine 4.0mmol/L group it was the most obvious (p <0.05). Detected by Western-blot, it was found that, compared with control group, there was no obvious change of protein of Sirt-1 and eNOS inaconine 0.20 mg/ml group, but in homocysteine 4.0 mmol/L model group, expression of Sirt-1 and eNOS protein weakened obviously, and in aconine groups, expression of Sirt-1 and eNOS protein enhanced, and in aconine 0.20 mg/ml plus homocysteine 4.0 mmol/L group it was the most obvious (p <0.05). Detected by fluorescent quantitation, it was found that, compared with control group, there was no obvious change of mRNA of Sirt -1 and eNOS in aconine 0.20 mg/ml group, but in homocysteine 4.0mmol/L model group, expression of Sirt-1 and eNOS mRNA weakened obviously, and in aconine groups, expression of Sirt-1 and eNOS mRNA enhanced, and in aconine 0.20 mg/ml Plus homocysteine 4.0 mmol/L group, it was the most obvious (p <0.05).
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CONCLUSIONS Homocysteine may injure EAhy926 cell by suppressing the expression of Sirt-1 then suppressing the expression of eNOS system, while aconine may protect EAhy926 cell by enhancing the expression of caveolin-1 then enhancing the expression of eNOS system.
GW26-e5354 Suv39h1 Promotes Neointima Formation in Diabetes
Jing Chen, Jing Zhang, Changwu Xu, Qi Hu, Shuo Yang, Lin Xu, Jian Yang, Xiaorong Hu, Hong Jiang Renmin Hospital of Wuhan University OBJECTIVES Patients with diabetes are at an increasing risk of vascular complications. Suv39h1, a histone methyltransferase, is suggested to protect the vascular smooth muscle cells (VSMCs) from the metabolic memory and proinflammatory phenotype in diabetes (DM). Yet the direct effects of Suv39h1 on DM-induced vascular remodeling remain largely elusive.
METHODS In this study, by generating adenovirus expressing Suv39h1 (Ad-Suv39h1) or lentivirus expressing Suv39h1-targeting shRNA (LV-Suv39h1 shRNA), we evaluated the significance of Suv39h1, in VSMCs under diabetic conditions both in vitro and in vivo. In vitro, we examined the proliferative and migratory behavior as well as the underlying signaling molecules of VSMC in response to high glucose (30 mM, HG) treatment. In vivo, we induced diabetes in SD rats with intraperitoneal injection of streptozocin and established the common carotid artery balloon injury model. Microarray analysis was performed to identify altered gene profile in carotid arteries after balloon injury.
RESULTS In response to HG, the endogenous Suv39h1 level was significantly reduced by almost 50% in VSMCs. Following HG treatment, Ad-Suv39h1-infected VSMCs exhibited significantly higher proliferative and migratory capabilities than control group. In contrast, knocking down Suv39h1 by LV-Suv39h1 shRNA led to dramatically reduced proliferation and migration. To understand the molecular mechanisms, knocking down Suv39h1 reduced the levels of ID3, complement C3 and phosphor-ERK1/2 in response to HG, but increased the level of p21 and p27KIP1 as compared to control group. Overexpressing Suv39h1 has the opposite effect on the expression of these molecules.
Consistent with the in vitro observation, ectopic expression of Suv39h1 was sufficient to up-regulate complement C3 and ID3 (P < 0.05, as compared to Ad-Null), while knocking down Suv39h1 was capable of reducing these two molecules in injured vessels (P < 0.05, as compared to LV-NC shRNA). As we expected, Suv39h1 overexpression led to accelerated neointima formation, while knocking down Suv39h1 reduced it following carotid artery injury in diabetic rats. Finally, altering Suv39h1 level in vivo dramatically changed the expressions of myriad genes with various functions and participating in different biological processes revealed by microarray analysis. We identified 233 up-regulated, 221 down-regulated genes between Ad-Suv39h1 and Ad-Null group, and 849 up-regulated, 658 down-regulated genes between LV-Suv39h1 shRNA and LV-NC shRNA group. Further Gene Ontology (GO) analysis showed that these altered genes participated in diverse biological processes, such as metabolic processes, cell differentiation, cell development, response to external stimulus.
CONCLUSIONS This study reveals the novel functions of Suv39h1 within VSMC in diabetes and suggests its potential role as a therapeutic target for diabetic vascular injury.
GW26-e2216
Role of IKKa in high glucose concentration-induced endothelial cell dysfunction and insulin resistance by IKKa gene silencing
Fanghui Chen The First Affiliated Hospital of Gannan Medical University
OBJECTIVES The study is to investigate the effects of expression downregulation in IKKa on high glucose-induced vascular endothelial insulin resistance (IR) and dysfunction.
METHODS HUVECs were inoculated in a 6-well plate uniformly and were randomly divided into four groups, namely, Control group, HG group, Non-silencing shRNA group, and RNAi group, respectively. Control group were only treated with DMEM containing glucose (5.5 mmol/L) for 48h, while other groups were treated with DMEM containing glucose (33 mmol/L) for 48h and insulin(100 nmol/L) for 30 minutes post transfection. The expression levels of IKKa mRNA and protein, cell viability, NO and ET-1 level were detected.
RESULTS HUVECs were incubated in media containing 33mmol/L of glucose for 48h and 100nmol/L of insulin for 30 minutes, the cell viability was significantly decreased, showing significant difference between HG group and Control group (P < 0.01); it was also found that the levels of ET-1 was increased. however, the levels of NO was decreased, which had significant difference compared with Control group (P < 0.05). Downregulation of IKKa expression by its genesilencing decreased the expression levels of IKKa mRNA and its protein absolutely and may antagonize these changes in all abovementioned parameters induced by high glucose concentration and insulin, and there was significant difference between RNAi group and HG group (P < 0.05). However, the results of the Non-silencing shRNA group were similar to the High group and there was no significant difference between the two groups (P > 0.05).
CONCLUSIONS The silencing of IKKa gene could protect the HUVECs in high glucose-induced vascular endothelial insulin resistance (IR) and dysfunction. OBJECTIVES Atherosclerosis is an inflammatory disease in which interferon (IFN)-g, the signature cytokine of Th1 cells, plays a central role. We investigated whether Danlou Tablet, which promoting blood circulation and eliminating phlegm in Traditional Chinese Medicine, could decrease the expression of IFN-g or restain the Th1 cells activated to alleviate atherosclerosis in apolipoprotein E-deficient (ApoE-/-) mice.
GW26-e2219 Danlou Tablet Decreases Cytokine IFN-g and Attenuates the Progression of Atherosclerosis
METHODS Eight-week old ApoE-/-mice fed a high-fat diet for 16 weeks, at the mean time were randomly divided into six groups for 16-wk. Control group that fed a chow diet and received no treatment, other five groups fed a high-fat diet, model group that also received no treatment, low-dose DLT group (1 g/kg/d), moderate-dose DLT group(2g/kg/d), high-dose DLT group (4g/kg/d) were administered Danlou Tablet suspension, and atorvastatin group that were treated with atorvastatin. Cell suspensions were obtained from the spleens of five randomly chosen mice from each group at the 16 week. The flow cytometry analysis were used to detect the percentages of CD4þ IFNgþ (Th1 cells) in the spleen cell suspensions. Immunohistochemical . 6 6 , N O . 1 6 , S U P P L S , 2 0 1 5 C93
